Treatment of infantile haemangiomas: recommendations of a European expert group.
about
Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Nd:YAG and pulsed dye laser therapy in infantile haemangiomas: a retrospective analysis of 271 treated haemangiomas in 149 children.When to stop propranolol for infantile hemangioma.Incidence, Treatment Patterns, and Health Care Costs of Infantile Hemangioma: Results of a Retrospective German Database Analysis.Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies.Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.Blood Pressure Monitoring During the Induction and Maintenance Period of Propranolol Therapy for Complicated Infantile Hemangiomas: A Prospective Study of 109 Infants.Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma: a case report.Infantile hemangiomas with conjunctival involvement: An underreported occurrence.Association of ATF4 Expression With Tissue Hypoxia and M2 Macrophage Infiltration in Infantile Hemangioma.Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.Advances in the Medical Management of Vascular Anomalies.Efficacy and safety of oral propranolol for infantile hemangioma in Japan.Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study.
P2860
Q33577048-8CB02788-EDEE-4E25-B00D-74286507EE89Q36211734-BF5E6A99-FADB-4FFC-A3A5-BFDFBFFA4FBFQ37657969-7146D8D8-C0CD-4E59-BC42-CE098E49EF90Q38694569-329B0287-E873-411E-8CE5-72462747E111Q38958282-F49E02FB-931E-47C4-BD1D-C8FF3F418F2BQ40424734-6C82A4E6-2545-47F3-B4F7-C5894DEAF92BQ40517442-4C9F3CDA-1E8D-46AE-8399-FAB81EE15CC9Q45739121-85C17642-0BF9-4649-BAFD-1232B454AF80Q46844431-EE31F840-9D22-4F14-A470-2F9AAD1316ADQ47911411-A6332FF2-7708-41F8-95F8-E08C374C1A06Q49379372-64CF999B-ACA3-4BC3-B33E-967885CCAC3DQ49711115-F5E2A9B5-0897-4B88-A890-B35C5E553C31Q53500320-AABDC9AF-80DC-48D6-B7ED-BCB4DE158925Q55266898-B5C22875-64A7-49E5-9D71-41FF6F5796CF
P2860
Treatment of infantile haemangiomas: recommendations of a European expert group.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Treatment of infantile haemangiomas: recommendations of a European expert group.
@ast
Treatment of infantile haemangiomas: recommendations of a European expert group.
@en
type
label
Treatment of infantile haemangiomas: recommendations of a European expert group.
@ast
Treatment of infantile haemangiomas: recommendations of a European expert group.
@en
prefLabel
Treatment of infantile haemangiomas: recommendations of a European expert group.
@ast
Treatment of infantile haemangiomas: recommendations of a European expert group.
@en
P2093
P2860
P1476
Treatment of infantile haemangiomas: recommendations of a European expert group.
@en
P2093
Agneta Troilius Rubin
Arnold P Oranje
Christine Léauté-Labrèze
Damien Bonnet
Eulalia Baselga
John I Harper
Laurence M Boon
Lisa Weibel
Marta Ciofi Degli Atti
Maya El Hachem
P2860
P2888
P304
P356
10.1007/S00431-015-2570-0
P577
2015-05-29T00:00:00Z